Clinical Trials Sponsored by Beijing Biostar Technologies, Ltd

Total 17 results

Biostar Pharma, Inc.

Recruiting

Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors

Advanced Solid Tumor

United States
Beijing Biostar Pharmaceuticals Co., Ltd.

Recruiting

Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Beijing Biostar Pharmaceuticals Co., Ltd.

Recruiting

Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer

Breast Cancer

China
Beijing Biostar Pharmaceuticals Co., Ltd.
Chengdu Biostar Pharmaceuticals

Completed

Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）

Advanced Non-small Cell Lung Cancer

China
Beijing Biostar Pharmaceuticals Co., Ltd.
Chengdu Biostar Pharmaceuticals

Recruiting

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors

Solid Tumor

China
Beijing Biostar Pharmaceuticals Co., Ltd.
Chengdu Biostar Pharmaceuticals

Completed

PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast Cancer

Advanced and Metastatic Breast Cancer

China
Beijing Biostar Pharmaceuticals Co., Ltd.
Chengdu Biostar Pharmaceuticals

Suspended

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer

Advanced or Metastatic CRC

China
Beijing Biostar Pharmaceuticals Co., Ltd.

Recruiting

Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Locally Advanced or Metastatic Non-Small Cell Lung Cancer

China
Beijing Biostar Pharmaceuticals Co., Ltd.

Completed

Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer

Breast Cancer

China
Wicab Technologies (Beijing) Co., Ltd.

Completed

Evaluate the Safety and Effectiveness of Electronic Vision-aid Device

the Blind

China
Henan Cancer Hospital
Qilu Pharmaceutical Co., Ltd.; Beijing Biostar Pharmaceuticals Co., Ltd.

Not yet recruiting

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

HER-2 Negative Breast Cancer
Peking University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Beijing Biostar Pharmaceuticals...

Recruiting

Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer

Esophageal Cancer

China
Sun Yat-sen University
Hunan Cancer Hospital; Beijing Biostar Pharmaceuticals Co., Ltd.

Recruiting

Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms | Locally Advanced or Metastatic Breast Cancer

China
Peking Union Medical College Hospital
ESCO Beijing Technologies Co., Ltd.

Unknown

Preterm Birth Prediction by Measurement of Biomarkers in Cervical Vaginal Fluid (PBMBCVF)

Preterm Birth

China
Pinetree Health Technologies (Beijing) Co., Ltd.
Peking Union Medical College Hospital

Completed

China Pilot of ICOPE (Integrated Care for Older People) in Chaoyang

Aging | Healthy Aging | Utilization, Health Care

China
China Agricultural University
General Hospital of Chinese Armed Police Forces; Beijing Anzhen Hospital; Peking... and other collaborators

Completed

Effects of Probiotics on the Patients With End Stage Renal Disease (ESRD)

Kidney Failure, Chronic

China
Beijing Friendship Hospital
Beijing Ditan Hospital; Nanfang Hospital of Southern Medical University; Ruijin... and other collaborators

Active, not recruiting

Prediction System of Clinical Endpoint Events for Chronic Hepatitis B Patients

Chronic Hepatitis b

China

Clinical Trials Sponsored by Beijing Biostar Technologies, Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations